Lyrinel XL 5mg & 10mg prolonged release tablets

Company:
Janssen Sciences Ireland (a Johnson & Johnson Company)
Status:
Discontinued
Legal Category:
Product subject to medical prescription which may be renewed (B)
Active Ingredient(s):
Oxybutynin Hydrochloride
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

PA22612/008/001

5 milligram(s)

G04BD,G04BD04

Prolonged-release tablet

PA22612/008/002

10 milligram(s)

G04BD,G04BD04

Prolonged-release tablet